Ongoing Infectious Disease Studies Update - June 20, 2023
Latest number of infectious disease clinical trials from ClinicalTrials.gov.
As of June 20, 2023, there are 911 infectious disease studies in Phases I-III that are recruiting, not yet recruiting, or in the interventional stage according to ClinicalTrials.gov. A breakdown by region via a global map can be found below.
911 Studies found for: Recruiting, Not yet recruiting Studies | Interventional Studies | Infectious Disease | Phase I, II, III | Industry
Source: ClinicalTrials.gov
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Roche’s Susvimo Lands FDA Approval for Diabetic Retinopathy Based on Phase III Pavilion Trial Data
May 22nd 2025One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months achieved superior improvements on the Diabetic Retinopathy Severity Scale.
